Hello and welcome to Danny in the Valley. Thank you for tuning in. We have a fabulous show for you today.

But before we get to it, another milestone. So you may remember last week was show number 100.

This week, our 500,000th, listen. 500,000, halfway to a million, which is incredible, especially given that the first season, season and a half was, you know, slim pickings when it came to listeners.

It's a very gradual climb from a very, very low base, but now we're cooking.

So thank you so much for continuing to listen. If you dig what

you are hearing, of course, I've got to ask. Do me a favor. Tell a friend. Tell 10. Or give a

rating on iTunes. Do both. Do neither. Either way, thank you for everyone for staying tuned in,

and I'll keep trying to track down interesting people for you.

So, that's it.

Now, let's get to today's show.

Yo, technology.

What is it all about?

If you look at where the alcohol market is now, we are the cannabis equivalent to people that still

bootlegging moonshine into the country.

This week on the program we are talking all things wacky-backy, sensamilla, reifer madness.

All of it, yes, weed is growing up quickly into a proper business, both as a

consumer product and potentially as a medical treatment for all kinds of diseases and ailments.

So, I took advantage of my recent trip to L.A. at the Milken Conference. Yep, another one from

my few days there. And I sat down with Neil

Mahapatra. And Neil is the founder of Kingsley Capital Partners, which is a London-based

investment firm, one of whose activities is starting cannabis companies. He's got two of them,

one working on medical treatments, the other a consumer brand, which I must say has a very good name.

...